Clinician differences in attitudes and perceptions on the use of long-acting injectable antipsychotic agents in treating patients with schizophrenia: results from the US DECIDE survey
Sign Up to like & getrecommendations! Published in 2025 at "BMC Psychiatry"
DOI: 10.1186/s12888-025-06565-1
Abstract: Long-acting injectable antipsychotics (LAIs) reduce relapses in schizophrenia; however, most clinicians reserve LAIs for nonadherence with oral antipsychotics (OAs) or severe disease. US psychiatric clinicians were surveyed regarding their schizophrenia management practices and use of… read more here.
Keywords: long acting; use; early use; lai use ... See more keywords
Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
Sign Up to like & getrecommendations! Published in 2018 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s167394
Abstract: Objective To assess expert consensus on barriers and facilitators for long-acting injectable antipsychotic (LAI) use and provide clinical recommendations on issues where clinical evidence is lacking, including identifying appropriate clinical situations for LAI use. Methods… read more here.
Keywords: long acting; lai use; expert consensus; patients clinical ... See more keywords